Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain DXCM message board posts where the ticker symbol DXCM has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest DXCM SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000009 Size: 6 KB
2018-02-20
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000080255-18-002442 (34 Act)  Size: 6 KB
2018-02-14 005-81357
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000315066-18-001221 (34 Act)  Size: 8 KB
2018-02-13 005-81357
18599730
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001274173-18-000008 (34 Act)  Size: 7 KB
2018-02-12 005-81357
18593385
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000932471-18-003732 (34 Act)  Size: 45 KB
2018-02-09 005-81357
18589238
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000902219-18-000273 (34 Act)  Size: 37 KB
2018-02-08 005-81357
18584030
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001193125-18-034015 (34 Act)  Size: 19 KB
2018-02-07 005-81357
18579305
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001088875-18-000028 (34 Act)  Size: 11 KB
2018-01-31 005-81357
18561049
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000007 Size: 5 KB
2018-01-25
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000005 Size: 6 KB
2018-01-18
More DXCM SEC Filings


Related news from
Tue, 20 Feb 2018
08:30:00 +0000
New Study Demonstrates that DexCom CGM Significantly Reduces Hypoglycaemia in People with Type 1 Diabetes on MDI
DexCom, Inc. (DXCM), has today released the findings of the HypoDE study, a multi-centre, randomised controlled trial (RCT) which was discussed on Friday 15th February at ATTD. The study found that the use of Dexcom continuous glucose monitoring (CGM) reduces the frequency and severity of hypoglycaemic events among high-risk individuals with type 1 diabetes treated with multiple daily injections (MDI) of insulin. Hypoglycaemia remains a key limiting factor in achieving optimal glycaemic control in people with type 1 diabetes, and the vast majority of these individuals are treated with MDI globally.
Mon, 19 Feb 2018
17:31:17 +0000
Is DexCom Inc’s (NASDAQ:DXCM) Balance Sheet Strong Enough To Weather A Storm?
Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like DexCom Inc (NASDAQ:DXCM), with a market cap of US$4.98B, are often out of the spotlight.Read More...
Mon, 12 Feb 2018
13:00:00 +0000
DexCom Announces Upcoming Conference Presentations
DexCom, Inc. today announced that management will present an update on DexCom at the following upcoming investor conferences:
Mon, 05 Feb 2018
15:32:07 +0000
Why Abbott Laboratories’ Product Pipeline Is Expected to Boost 2018
In fiscal 4Q17, Abbott Laboratories(ABT) invested ~6.9% of its total sales in R&D (research and development). In fiscal 2018, the company plans to invest ~7.5% of its total sales. Abbott Laboratories launched more than 20 new products in fiscal 2017. Abbott Laboratories now has an attractive product pipeline, boosted by the recent acquisitions—especially its acquisition of St. Jude Medical.
Fri, 02 Feb 2018
13:25:00 +0000
Investor Expectations to Drive Momentum within Valero Energy Partners LP, Middlesex Water, ForeScout Technologies, Calithera Biosciences, eBay, and DexCom — Discovering Underlying Factors of Influence
NEW YORK, Feb. 02, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Valero ...
Thu, 01 Feb 2018
13:00:00 +0000
DexCom Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call for February 27, 2018 at 4:30 p.m. Eastern Time.
DexCom, Inc. today announced that it plans to release its fourth quarter and full year 2017 financial results after market close on Tuesday, February 27, 2018. Management will hold a conference call to review the company's fourth quarter and full year 2017 performance starting at 4:30 p.m.
Wed, 31 Jan 2018
15:35:47 +0000
J&J’s Medical Device Segment Registered Strong Growth in 4Q17
Johnson & Johnson (JNJ) released its 4Q17 and fiscal 2017 results on January 23, 2018. The company reported sales growth across its three business segments: Pharmaceuticals, Medical Devices, and Consumer Businesses. The company’s medical device business contributed ~35% to J&J’s total sales in fiscal 4Q17.
Thu, 11 Jan 2018
13:02:48 +0000
See what the IHS Markit Score report has to say about Dexcom Inc.
Dexcom Inc NASDAQ/NGS:DXCM
Wed, 10 Jan 2018
15:30:00 +0000
UnitedHealthcare and Dexcom Bring Wearable Technology Solution, One-on-One Coaching to People Battling Type 2 Diabetes
UnitedHealthcare, the market leader in Medicare benefit plans1, and DexCom, Inc., the leader in continuous glucose monitoring for diabetes management, today announced an individualized glucose management pilot program driven by wearable technology to help people with Type 2 diabetes manage their condition in real time.
Wed, 10 Jan 2018
12:38:12 +0000
DexCom Estimates Strong Revenue Figures for Q4 and 2017
Dexcom (DXCM) to gain from strong sensor volumes, international revenues and expanding worldwide patient base in 2018.
Tue, 09 Jan 2018
18:12:50 +0000
Fitbit for Kids? FIT Considering Smartwatch for Children
A recent report claims that the company has been working for months to develop a version of Fitbit for kids. Several unnamed sources spoke about the matter, but didn’t provide details on how the devices would differ from current ones. The idea of developing a version of Fitbit for kids makes sense.
Mon, 08 Jan 2018
21:05:00 +0000
DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2017 and Provides Initial 2018 Outlook
DexCom, Inc. , the leader in continuous glucose monitoring , today reported that it achieved preliminary, unaudited revenue of approximately $218 million for the fourth quarter ended December 31, 2017, an increase of 27% over the fourth quarter of 2016.
Mon, 08 Jan 2018
15:31:19 +0000
Fibit Inc Invests in Blood Glucose Monitoring Startup
Fitbit Inc (NASDAQ:FIT) confirmed that it has made its first investment in a startup, in an effort to beat Apple Inc.’s (NASDAQ:AAPL) Apple Watch. The Fitbit investment is in a company called Sano, which aims to develop a wearable, coin-sized blood sugar monitor for diabetics. FIT stock popped on the news on Friday morning, but is now down 2.5% shortly after the bell Monday morning.
Thu, 04 Jan 2018
17:15:10 +0000
Medicare to cover new glucose monitor, giving Abbott an edge over rival Dexcom
Abbott's FreeStyle Libre continuous glucose monitor received Medicare reimbursement, the company said Thursday.
Thu, 04 Jan 2018
17:11:00 +0000
This News Explains Why DexCom Is Dropping Today
Shares slide after news breaks that a competitor's product nabs an important reimbursement win.
Thu, 04 Jan 2018
14:05:01 +0000
CMS to cover Abbott's glucose monitoring device
Abbott Laboratories said on Thursday its newly launched glucose monitoring device would be covered by the Centers for Medicare & Medicaid Services, expanding its usage to millions of diabetes patients in the United States. The device, FreeStyle Libre Flash, was approved by the U.S. Food and Drug Administration in September. It allows diabetes patients to continuously track blood sugar levels without having to prick their fingers.
Tue, 26 Dec 2017
14:20:02 +0000
The Zacks Analyst Blog Highlights: Bio-Rad Laboratories, Mazor Robotics, Tactile Systems, Eli Lilly and DexCom
The Zacks Analyst Blog Highlights: Bio-Rad Laboratories, Mazor Robotics, Tactile Systems, Eli Lilly and DexCom
Fri, 22 Dec 2017
19:33:07 +0000
4 MedTech Stocks to Explode in 2018
Standing at the threshold of 2018 it is imperative for the investors to find the means which can dilute the macroeconomic woes and help them gain more.
Wed, 20 Dec 2017
13:49:01 +0000
DexCom (DXCM) Banks on Collaborations, Competition Rife
DexCom's (DXCM) collaborative agreements should bring in cash in the form of milestone payments and royalties, and help expand product portfolio.
Tue, 12 Dec 2017
13:00:00 +0000
DexCom Announces Upcoming Conference Presentation
DexCom, Inc. today announced that management will present an update on DexCom at the following upcoming investor conference:



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This last year I have subscribed to two investment services, ValueForum and a well known income newsletter. ValueForum costs a little over 200 per year. The income newsletter costs about 400 per year. I am up 11% on investments made because I heard about them on ValueForum (of course, I do my own research on everything but the ideas came from ValueForum and there was always some discussion of the pros and cons of each investment on VF). I am down 8% on investments made because I heard about them from the income newsletter. I might also add that I often hear about breaking events immediately on ValueForum and a day or two later the same information is finally available from the newsletter. Hmmm...... which service is the better value?" more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards